help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leonard, C.
Right arrow Articles by Poulter, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonard, C.
Right arrow Articles by Poulter, L. W.

Am. J. Respir. Cell Mol. Biol., Vol 17, No. 3, 09 1997, 368-375.

Allergen-induced cytokine production in atopic disease and its relationship to disease severity

C Leonard, V Tormey, C Burke and LW Poulter
Department of Respiratory Medicine, James Connolly Memorial Hospital, Blanchardstown, Dublin, Ireland.

The Th2 cytokines, interleukin (IL)-4 and IL-5, have an important role in atopic disease. CD30 is a transmembrane molecule that may be expressed on a proportion of activated T-lymphocytes and has been reported to be a marker for Th2 phenotype. Our objective was to compare the in vitro cytokine responses and CD30 expression of peripheral blood mononuclear cells (PBMCs) to stimulation with house dust mite antigen (Dermatophagoides pteronyssinus) in atopic asthmatics, atopic nonasthmatics, and normal subjects, and to see if atopic asthmatic cytokine production correlated with symptomatic disease activity and whether cytokine production was allergen-specific. Eighteen atopic asthmatics (all were allocated a symptomatic disease score), 6 atopic nonasthmatics, and 7 healthy nonatopic individuals were studied. Resting serum IL-4 levels were measured, then PBMCs were separated using Lymphoprep density centrifugation and cultured in modified RPMI 1640 medium. PBMCs were stimulated with IL-2 alone or with D. pteronyssinus (1,000 subcutaneous units/ml) with IL-2 and harvested after 5 and 10 d. Using monoclonal antibodies and flow cytometry we obtained the percentage of CD4+ T cells expressing CD30 and the intensity of CD30 staining. Culture supernatants were analyzed for IL-4 and interferon gamma (IFN-gamma) using an enzyme-linked immunosorbent assay. In 9 atopic asthmatics PBMCs were also stimulated nonspecifically using phytohemagglutinin (PHA). IL-4 was detectable in the serum of atopic subjects but not in normal subjects. Stimulation of PBMCs with D. pteronyssinus produced significant amounts of IL-4 in atopic asthmatics and atopic nonasthmatics, but minimal quantities in normal subjects. Much lower levels of IFN-gamma were produced by atopic asthmatics in response to D. pteronyssinus compared to atopic nonasthmatics. IFN-gamma levels had an inverse correlation with asthmatic symptom score. CD4+ T-cell expression of CD30 also correlated inversely with IFN-gamma production and IFN-gamma:IL-4 ratio. PHA produced minimal levels of IL-4 compared to specific allergen stimulation. It is concluded that different groups of atopic patients exhibit different patterns of allergen-induced cytokine production. In vitro allergen-induced cytokine production in atopic asthmatics correlated with symptomatic disease activity, and is allergen-specific.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Harada, K. Nakashima, T. Hirota, M. Shimizu, S. Doi, K. Fujita, T. Shirakawa, T. Enomoto, M. Yoshikawa, H. Moriyama, et al.
Functional Polymorphism in the Suppressor of Cytokine Signaling 1 Gene Associated with Adult Asthma
Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 491 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. K. Teixeira, B. P. F. Fonseca, A. Vieira-de-Abreu, B. A. Barboza, B. K. Robbs, P. T. Bozza, and J. P. B. Viola
IFN-{gamma} Production by CD8+ T Cells Depends on NFAT1 Transcription Factor and Regulates Th Differentiation
J. Immunol., November 1, 2005; 175(9): 5931 - 5939.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
R. A. Joachim, D. Quarcoo, P. C. Arck, U. Herz, H. Renz, and B. F. Klapp
Stress Enhances Airway Reactivity and Airway Inflammation in an Animal Model of Allergic Bronchial Asthma
Psychosom Med, September 1, 2003; 65(5): 811 - 815.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
C. Cole Johnson, D. R. Ownby, E. M. Zoratti, S. Hensley Alford, L. K. Williams, and C. L. M. Joseph
Environmental Epidemiology of Pediatric Asthma and Allergy
Epidemiol. Rev., December 1, 2002; 24(2): 154 - 175.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES
Endogenous Inhibitory Mechanisms in Asthma
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S176 - 181.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. B. CLOUGH, K. A. KEEPING, L. C. EDWARDS, W. M. FREEMAN, J. A. WARNER, and J. O. WARNER
Can We Predict Which Wheezy Infants Will Continue to Wheeze?
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1473 - 1480.
[Abstract] [Full Text]


Home page
ThoraxHome page
K F Chung and P J Barnes
Cytokines in asthma
Thorax, September 1, 1999; 54(9): 825 - 857.
[Full Text]


Home page
Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1997 American Thoracic Society.
  ATS Coding and Billing Quarterly